One small pharma company is meeting the challenge of COVID-19 by finding new ways to support the practices of its specialist physician customers.
Senate Finance Committee Chairman and Republican Chuck Grassley and the panel’s leading Democrat, Senator Ron Wyden, announced a bipartisan proposal to lower the Rx drug prices.
